fundsforNGOs

Innovate UK Antimicrobial Resistance: Reducing the Impact of Drug Resistant Pathogens

CCSA: COVID-19 Relief Fund Phase II (United States)

Deadline: 27 October 2016

Innovate UK on behalf of the Department of Health is seeking applications for its program entitled “Antimicrobial Resistance” to invest up to £4 million to support the UK’s capability to conduct research into antimicrobial resistance (AMR).

The aim of the program is to develop new products and services that will reduce the impact of drug resistant pathogens, slow down the emergence of new ones, and produce new products and services including drugs, vaccines and diagnostics.

Aims

Funding Information

Funding awards are likely to be in the range of £200,000 and £2 million. Exceptional applications may be awarded more and organisations can request less than £200,000.

Eligibility Criteria

To apply you must:

How to Apply

Applicants can apply via given website.

Eligible Country: United Kingdom

For more information, please visit Innovate UK Antimicrobial Resistance.

Exit mobile version